InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Grayzel David S., Director. Officer active across 2 companies, notably Aerovate Therapeutics, Inc.. Aggregated, 3 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €308k. Activity tracked since 9 April 2024. The latest transaction was filed on 9 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Grayzel David S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
11,882 shares@ US$28.15100.0% of flowCommon StockSEC:0001415889-24-010709:0
2,945,453 sharesCommon StockSEC:0001209191-23-048755:0
2,568,165 sharesCommon StockSEC:0001104659-21-089435:0
3 of 3 declarations
About Grayzel David S.
Grayzel David S. is a Director at Aerovate Therapeutics, Inc. In this role, he oversees the company's activities and participates in strategic decision-making. David is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.
